Earlier this week, the Food & Drug Administration (FDA) released a Part 15 public hearing announceme...
“Translating science into strategy is key to achieving short- and long-term business goals.”
Principal Research Scientist
Demonstrate Product Value
Delivering end-to-end scientific and commercial support and solutions, we work closely with you to ensure your FDA label effectively and accurately demonstrates the value of your product to payers, providers, and patients to secure long-term adoption and reimbursement. We solve today’s regulatory and commercial challenges and help you anticipate and navigate future demands in drug development and managing a product’s lifecycle.
Whether you are from a life sciences company, plan, or provider, we have you covered.
Biologics, Biosimilars & Interchangeables
Clinical Guidelines & Publication Planning
Due Diligence & Commercial Viability Analysis
Evidence Communication, Advertising & Promotion
Expanded Access Pathway, Compassionate Use & Right-to-Try
FDA Approval Pathway Strategy
FDA Engagement Approaches
FDAMA 114 Assessment & Insight
Label Differentiation & Value Proposition
Legal, Regulatory & Policy Analysis Impact & Considerations
Life-Cycle Pipeline Management
Patient Engagement & Drug Development
Real-World Data/Evidence for Regulatory Decision Making
Regulatory Risk Mitigation